Boofonomics

Trulieve calls it “pruning to bloom.” The reality? Exiting California, Massachusetts, and Nevada while bragging about 725,000 loyalty members — and still ignoring the death of Lorna McMurrey. Our exposé uncovers regulator silence, financial spin, and a company pivoting straight into a mountain.

Canncestry.com™, the cannabis DNA test from Ancestry.com, just confirmed your $65 eighth is the same Blue Dream you smoked in 2012. Turns out genetic transparency isn’t good for business.

Trump mentioned weed. The agencies are still broken. And now the federal cannabis strategy is a four-way clusterfuck with no safe word. Rescheduling is the headline — but the chaos behind it is where the real story lives.

New York’s $1.5B cannabis market is now monitored by a login screen no one can access — thanks to vendor chaos, OCM delays, and the Track-and-Trace Grift Economy™.

Cannabis labs across the U.S. are inflating THC, hiding mold, and dodging regulators. Meanwhile, brands and MSOs play along to chase profits. We break down the financial rot—lab by lab, state by state.

The DEA’s mid-2025 cannabis report proves reform is a farce. Quotas stay. Licenses stall. Rescheduling is just theater. Boof breaks down the real playbook.

McKee Foods enters the THC arena with “Lil Debbie,” a Black cartoon reboot of their iconic snack cake brand—now selling infused brownies at gas stations. It’s not a rebrand. It’s weaponized nostalgia for stoners, with a side of corporate cringe.

Cresco just bailed on California. Again. Their $825M distro dream is now part of the California Exit Index — a growing graveyard of MSOs who thought capital beats culture. Here's why they failed, what it says about weed finance, and who’s next.